C. Knall et al., ANALYSIS OF CORECEPTOR VERSUS ACCESSORY MOLECULE FUNCTION OF CD8 AS ACORRELATE OF EXOGENOUS PEPTIDE CONCENTRATION, Molecular immunology, 31(12), 1994, pp. 875-883
Substitution in the alpha 3 domain of class I molecules can ablate the
recognition of target cells by CD8 dependent cytotoxic T lymphocytes.
This effect has been attributed to a destruction of the CD8 alpha bin
ding site on the class I molecule, a hypothesis which is consistent wi
th results obtained in conjugate binding assays. To assess the relativ
e contribution to CTL activation of CD8 functioning as either a corece
ptor or an accessory molecule, we have compared the ability of H-2K(b)
ovalbumin reactive CTL to lyse M12.C3 or T2 cells transfected with an
H-2K(b) gene encoding a wild type or mutant (CD8 nonbinding) alpha 3
domain. To establish that the substitution in the alpha 3 domain does
not alter the ability of the H-2K(b) molecule to bind the antigenic pe
ptide, we have compared the binding of the ovalbumin derived H-2K(b) r
estricted peptide (SIINFEKL) to T2 cells expressing either the CD8 bin
ding or the CD8 nonbinding form of H-2K(b). This peptide conjugated wi
th FITC bound equally well to T2 cells expressing either form of H-2K(
b). Upon binding of this peptide, both forms of the H-2K(b) molecule u
nderwent the same conformational change as revealed by increases in th
e expression of particular serological epitopes. Furthermore, inhibiti
on of the binding of the SIINFEKL peptide to both the wild type and mu
tant H-2K(b) was observed following pretreatment of the cells with sim
ilar amounts of other H-2K(b) restricted peptides derived from Sendai
and Vesicular Stomatitis viruses. When the transfected M12 cells were
tested for their ability to serve as targets for an anti-H-2K(b) ovalb
umin CTL clone, cells expressing the mutant H-2K(b) molecule required
the addition of 100-fold more exogenous peptide than did cells express
ing the wild type molecule in order to obtain significant lysis. These
data strengthen the previous hypothesis that CD8 functions much more
efficiently as a coreceptor than as an accessory molecule for T cell e
ffector function.